Genetic risk factors for dilated cardiomyopathy

Genetic risk factors for dilated cardiomyopathy

Aim. To study the diagnostic significance of genetic testing in patients with dilated cardiomyopathy (DCM), identify predictors of life-threatening ventricular tachyarrhythmias (VTAs) and assess adverse clinical outcomes in different genetic groups.Material and methods. The study included 126 unrela...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. G. Vaikhanskaya, L. N. Sivitskaya, O. D. Levdansky, T. V. Kurushko, N. G. Danilenko
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-11-01
Series:	Российский кардиологический журнал
Subjects:	sudden cardiac death genetic screening dilated cardiomyopathy lamin a/c gene (lmna) titin gene (ttn) risk predictors
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4628
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dilated cardiomyopathy: reconceptualization of the problem
by: T. G. Vaykhanskaya, et al.
Published: (2019-05-01)

Variants of RBM20 gene in pediatric patients with dilated cardiomyopathy
by: A. M. Kiselev, et al.
Published: (2019-11-01)

AN ORPHAN PHENOTYPE OF CARDIOGENITAL LAMINOPATHY — MALOUF SYNDROME
by: T. G. Vaykhanskaya, et al.
Published: (2016-11-01)

Non-compaction and dilated cardiomyopathy: genotypic, phenotypic and prognostic differences
by: T. G. Vaykhanskaya, et al.
Published: (2022-11-01)

Atrial fibrillation in patients with dilated cardiomyopathy: prevalence, risk factors and prognostic significance
by: T. G. Vaikhanskaya, et al.
Published: (2023-11-01)

Sudden cardiac death risk stratification in dilated cardiomyopathy: a state of the art review
by: B. Sh. Berdibekov, et al.
Published: (2025-05-01)

Antisense‐mediated exon skipping: a therapeutic strategy for titin‐based dilated cardiomyopathy
by: Michael Gramlich, et al.
Published: (2015-03-01)

EFFICACY OF CARDIOVERTER-DEFIBRILLATORS IN PREVENTION OF SUDDEN DEATH AND OVERALL MORTALITY DECREASE IN PATIENTS WITH THE SYNDROME OF DILATION CARDIOMYOPATHY: DIFFERENTIAL APPROACH
by: O. V. Blagova, et al.
Published: (2018-03-01)

Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Right Balance Between Risks and Benefits
by: Lorenzo‐Lupo Dei, et al.
Published: (2025-06-01)

SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY: SEARCH FOR NEW RISK FACTORS
by: N. S. Krylova, et al.
Published: (2017-02-01)

Restrictive cardiomyopathy: difficulties desminopathy diagnostics
by: T. G. Vaikhanskaya, et al.
Published: (2019-11-01)

The non-compact left ventricle cardiomyopathy: clinical features and diagnostic capabilities
by: E. A. Mershina, et al.
Published: (2015-12-01)

CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
by: E. V. Privalova, et al.
Published: (2013-02-01)

Carvajal syndrome: a brief overview and clinical case of cardiomyopathy, associated with compound heterozygous mutations of the desmoplakin gene
by: T. G. Vaikhanskaya, et al.
Published: (2018-11-01)

LMNA-Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
by: E. V. Resnik, et al.
Published: (2024-10-01)

Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy
by: Fan J, et al.
Published: (2025-07-01)

Similar burden of rare genetic variants in ischemic and non-ischemic dilated cardiomyopathy
by: Louie Cao, et al.
Published: (2025-04-01)

Pathogenic Variant Rs1471414348of the TTN Gene in the Patient with Familial Left Venticular Noncompaction Cardiomyopathy
by: O. V. Kulikova, et al.
Published: (2019-09-01)

Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers
by: Philip M. Croon, et al.
Published: (2025-07-01)

A paradigm shift in the concept of arrhythmogenic cardiomyopathy: expanding the clinical and genetic spectrum, new diagnostic criteria for left ventricular phenotypes
by: T. G. Vaikhanskaya, et al.
Published: (2020-11-01)

Association of SCN5A gene polymorphism with dilated cardiomyopathy
by: S. Yu. Nikulina, et al.
Published: (2021-09-01)

Prognostic model for the development of cardiomyopathies based on genetic predictors
by: S. Yu. Nikulina, et al.
Published: (2024-12-01)

Risk stratification of sudden cardiac death in heart failure patients: is left ventricular ejection fraction alone sufficient?
by: N. N. Ilov, et al.
Published: (2021-02-01)

Biventricular hypertrophic cardiomyopathy with ACTC1 and LDB3 mutations, results of primary prevention of sudden cardiac death: а case report
by: V. N. Larina, et al.
Published: (2025-05-01)

Electrocardiographic parameters and features of ventricular arrhythmias in various arrhythmogenic cardiomyopathy forms in the pediatric population: a systematic review and meta-analysis
by: D. Yu. Alekseeva, et al.
Published: (2022-09-01)

<i>MYBPC3</i>-associated cardiomyopathy: features of the course and prospects for specific therapy
by: D. A. Nefedova, et al.
Published: (2025-02-01)

Predictors of heart failure in patients with cardiomyopathies of various origins
by: O. O. Kuznetsova, et al.
Published: (2023-11-01)

Contribution of electrocardiography to the diagnosis of cardiomyopathies and athletic heart syndrome
by: O. S. Chumakova, et al.
Published: (2020-09-01)

Biventricular arrhythmogenic cardiomyopathy and sudden cardiac death: forensic perspectives based on autopsy case report
by: Nora Fnon, et al.
Published: (2025-07-01)

Comparative analysis of implantable cardioverter-defibrillator efficacy in ischemic and non-ischemic cardiomyopathy in patients with heart failure
by: Emre Demir, et al.
Published: (2025-07-01)

Electrocardiogram May Fail to Identify Proportion of High-Risk Individuals: Analysis of Series of 50 Sudden Death Cases
by: Mariela Salar-Alcaraz, et al.
Published: (2025-02-01)

Clinical characteristics of various arrhythmogenic cardiomyopathy phenotypes in the pediatric population: a systematic review and meta-analysis
by: D. Yu. Alekseeva, et al.
Published: (2022-12-01)

Thyroid status and levothyroxine natrium effectiveness in patients with dilated cardiomyopathy
by: T. A. Abdullaev, et al.
Published: (2010-06-01)

Exploring the Current Status of Risk Stratification in Hypertrophic Cardiomyopathy: From Risk Models to Promising Techniques
by: Alexandros Kasiakogias, et al.
Published: (2025-03-01)

RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE
by: T. G. Kulikova, et al.
Published: (2015-09-01)

CARDIOMYOPATHY IN THE FRIEDREICH ATAXIA: CLINICAL PRESENTATION AND DIAGNOSTICS OF COMPLICATIONS
by: Е. I. Fomicheva, et al.
Published: (2017-11-01)

Mixed phenotype cardiomyopathy, associated with DSP genetic variant: a case report and literature review.
by: I. V. Shlyk, et al.
Published: (2020-11-01)

Clinical profile of restrictive cardiomyopathy in children at a South Indian tertiary care cardiac center: A retrospective three decade experience
by: Gousia Mukhtar Kawoos, et al.
Published: (2025-01-01)

Heart transplantation in secondary dilated cardiomyopathy due to myocarditis. Case report
by: D. V. Romashova, et al.
Published: (2023-06-01)

Biventricular Thrombi in a Patient With Dilated Cardiomyopathy
by: Saba Mohammadzadeh, et al.
Published: (2025-08-01)